DDEFL1/ASAP1 activators are a group of chemicals that indirectly influence the activity or expression of DDEFL1/ASAP1 by modulating associated cellular processes, particularly those involved in actin cytoskeleton dynamics and cell motility. These activators do not directly target DDEFL1/ASAP1 but affect the broader cellular environment and signaling processes in which it functions. Actin dynamics modulators such as Jasplakinolide and Cytochalasin D are significant for their direct effects on actin filaments, potentially impacting DDEFL1/ASAP1's role in cytoskeletal organization. Phosphatidylinositol 4,5-Bisphosphate, a key signaling lipid, is also important in actin remodeling and may influence DDEFL1/ASAP1 activity.
Inhibitors of Rho-family GTPases (like Rac1 and Cdc42) and their downstream effectors (such as PAK and ROCK) are relevant due to their roles in regulating the actin cytoskeleton, which could indirectly affect DDEFL1/ASAP1's function. Forskolin, by elevating cAMP levels, can influence cell signaling pathways associated with cytoskeletal dynamics. PI3K inhibitors like LY294002 target key signaling molecules involved in cell motility and cytoskeletal reorganization, potentially impacting DDEFL1/ASAP1. Wiskostatin, an inhibitor of N-WASP, and Arp2/3 complex inhibitors, which affect actin nucleation, are also pertinent in the context of actin dynamics regulation. In summary, DDEFL1/ASAP1 activators encompass a range of chemicals that, through their roles in actin cytoskeleton dynamics, cell motility, and related signaling pathways, can indirectly modulate the activity or expression of DDEFL1/ASAP1. Understanding these interactions is crucial for insights into the regulation of cytoskeletal organization and cell migration and the potential modulation of DDEFL1/ASAP1's role in these essential cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide stabilizes actin filaments, potentially impacting actin dynamics where DDEFL1/ASAP1 is involved. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
These inhibitors affect actin cytoskeleton dynamics, potentially impacting DDEFL1/ASAP1 function. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Elevates cAMP levels, potentially influencing signaling pathways associated with DDEFL1/ASAP1. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
Target Rac1 GTPase, involved in actin cytoskeleton remodeling and possibly affecting DDEFL1/ASAP1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Target phosphoinositide 3-kinases, which are involved in cell signaling, potentially affecting DDEFL1/ASAP1. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
Inhibitor of the N-WASP, which is part of the actin remodeling pathway, potentially impacting DDEFL1/ASAP1. | ||||||